Puma Biotechnology, Inc. (PBYI) Stock Price History
Historical prices from 2012 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
PBYI Stock Price Trajectory (2012–2026)
As of March 1, 2026, Puma Biotechnology, Inc. (PBYI) trades at $5.70, representing a +59.2% return over the past year. The stock has delivered a -11.0% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $279.37 on August 26, 2014. From this peak, PBYI has corrected -98.0%, currently trading 16% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), PBYI has underperformed the peer group average. Compare PBYI vs RVMD →
Historical Price Data
Showing 30 of 3,483 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 6.30 | 6.86 | 5.50 | 5.70 | 5 | -25.00% |
| 2026-02-26 | 7.68 | 7.68 | 7.33 | 7.60 | 7 | -1.04% |
| 2026-02-25 | 7.51 | 7.68 | 7.43 | 7.68 | 7 | +2.54% |
| 2026-02-24 | 7.24 | 7.58 | 7.05 | 7.49 | 7 | +5.34% |
| 2026-02-23 | 6.82 | 7.15 | 6.77 | 7.11 | 7 | +4.10% |
| 2026-02-20 | 6.78 | 6.86 | 6.65 | 6.83 | 6 | +0.59% |
| 2026-02-19 | 6.63 | 6.84 | 6.50 | 6.79 | 382K | +1.65% |
| 2026-02-18 | 6.78 | 6.91 | 6.64 | 6.68 | 276K | -1.47% |
| 2026-02-17 | 6.79 | 6.85 | 6.72 | 6.78 | 27K | -0.59% |
| 2026-02-13 | 6.79 | 6.99 | 6.70 | 6.82 | 301K | +0.29% |
| 2026-02-12 | 6.67 | 6.83 | 6.48 | 6.80 | 425K | +2.41% |
| 2026-02-11 | 6.63 | 6.69 | 6.37 | 6.64 | 255K | +0.45% |
| 2026-02-10 | 6.83 | 6.98 | 6.59 | 6.61 | 323K | -3.92% |
| 2026-02-09 | 6.88 | 6.98 | 6.76 | 6.88 | 410K | -0.86% |
| 2026-02-06 | 6.88 | 7.05 | 6.85 | 6.94 | 408K | +2.21% |
| 2026-02-05 | 7.01 | 7.29 | 6.75 | 6.79 | 433K | -4.37% |
| 2026-02-04 | 7.14 | 7.20 | 6.91 | 7.10 | 638K | 0.00% |
| 2026-02-03 | 6.79 | 7.14 | 6.79 | 7.10 | 654K | +4.11% |
| 2026-02-02 | 6.44 | 6.93 | 6.43 | 6.82 | 471K | +5.25% |
| 2026-01-30 | 6.39 | 6.50 | 6.27 | 6.48 | 306K | +0.78% |
| 2026-01-29 | 6.33 | 6.49 | 6.33 | 6.43 | 290K | +1.74% |
| 2026-01-28 | 6.60 | 6.64 | 6.26 | 6.32 | 285K | -3.81% |
| 2026-01-27 | 6.43 | 6.64 | 6.43 | 6.57 | 361K | +2.18% |
| 2026-01-26 | 6.39 | 6.47 | 6.27 | 6.43 | 441K | +0.16% |
| 2026-01-24 | 6.82 | 6.90 | 6.34 | 6.42 | 551K | 0.00% |
| 2026-01-23 | 6.82 | 6.90 | 6.34 | 6.42 | 556K | -6.41% |
| 2026-01-22 | 6.94 | 7.21 | 6.55 | 6.86 | 767K | -0.44% |
| 2026-01-21 | 6.64 | 6.90 | 6.55 | 6.89 | 603K | +4.39% |
| 2026-01-20 | 6.34 | 6.66 | 6.29 | 6.60 | 647K | +3.61% |
| 2026-01-16 | 6.38 | 6.48 | 6.34 | 6.37 | 248K | -0.16% |
See PBYI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PBYI Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PBYI vs AGIO
See how PBYI stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has PBYI stock performed recently?
PBYI returned +59.2% over the past year, beating its 5-year annualized CAGR of -11.0%. The stock trades above its 200-day moving average, confirming the uptrend.
What is PBYI's all-time high price?
Puma Biotechnology, Inc. reached $279.37 on 2014-08-26. The 52-week high is $7.68. Current 1-year return of +59.2% places the stock closer to historical peaks.
Where can I download PBYI historical price data?
This page provides PBYI daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.